Sometime in late 2024, a Wikipedia editor scanning a newly created biography noticed something off. The article was fluent, ...
Bridging cancer innovation and patient access through a trusted multi-agent platform. Cancer patients are not lost ...
Waypoint Bio, an AI-native biotech company using spatial biology to design next-generation CAR T therapies for solid tumors, announced today that it closed a $20M Series A financing round.
CHICAGO--(BUSINESS WIRE)--Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical ...
OTTAWA, Ontario--(BUSINESS WIRE)--Today, BioTalent Canada and Propero Learning Systems launched AI Fundamentals for the Bio-economy, a new foundational Artificial Intelligence training course geared ...
Researchers at the University of Osaka have developed a new AI-powered technology for better control of cyborg insects ...
Massive Bio, a leader in AI-enabled patient recruitment and oncology solutions, today announced expanded access to oncology ...
Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...